Secretaria de Estado da Saúde - BVS

O objetivo deste trabalho foi avaliar a atividade in vitro dos óleos essenciais de Cinnamomum cassia, Eucalyptus citriodora; Eucalyptus globulus, Eugenia caryophyllus, Melaleuca alternifólia, Myristica fragans, Ocimum basilicum, Origanum majorana, Origanum vulgare, Rosamarinus officinalis, Salvia sclarea, Schinus terebinthifolius, Thymus vulgaris e Zingiber officinale, bem como dos compostos químicos desses óleos essenciais, com as menores concentrações fungicidas mínimas sobre três isolados biológicos de Candida auris de origem humana. Determinar e avaliar in vitro as concentrações fungicidas mínimas dos antifúngicos sintéticos anfotericina B, cetoconazol, flucitocina, fluconazol, itraconazol e voriconazol sobre Candida auris. Para avaliação da atividade antifúngica e obtenção da concentração fungicida mínima (CFM) utilizou-se a técnica de microdiluição em caldo, na base 2, em meio RPMI 1640, acrescido de tensoativo Tween20, e a confirmação da inibição em Agar Sabouraud dextrose, a 37ºC por 24hs. Para a avaliação da sensibilidade a anfotericina B, cetoconazol, flucitocina...(AU)

The objective of this search was to evaluate the in vitro activity of the essential oils Cinnamomum cassia, Eucalyptus citriodora; Eucalyptus globulus, Eugenia caryophyllus, Melaleuca alternifolia, Myristica fragans, Ocimum basilicum, Origanum majorana, Origanum vulgare, Rosamarinus officinalis, Salvia sclarea, Schinus terebinthifolius, Thymus vulgaris and Zingiber officinale as well as the chemical compounds of these essencial oils with the lowest minimum fungicidal concentrations on three biological isolates of Candida auris of human origin. Determine and evaluate in vitro the minimum fungicidal concentrations of the synthetic antifungals amphotericin B, ketoconazole, flucitocin, fluconazole, itraconazole and voriconazole on Candida auris. To evaluate the antifungal activity and obtain the minimum fungicidal concentration (CFM), the broth microdilution technique was used in RPMI 1640 medium, plus Tween20 surfactant, and confirmation of inhibition in Sabouraud dextrose Agar, at 37ºC for 24 hours. For the evaluation of sensitivity to amphotericin B, ketoconazole, flucitocin, fluconazole, itraconazole and voriconazole, the commercial test E-test® was used. The three isolates were resistant to the oils Myristica fragans, Shinus terebinthifolius and Zenziber officinale. The other essential oils showed inhibitory activity on Candida auris. The three isolates were more sensitive to Cinnamomum cassia essential oil, with CFM of 0.00001 µg/mL for isolate 1 and CFM of 0.10 µg/mL for isolate 2 and CFM of 0.05 µg/mL for isolate 3. Thymus vulgaris also showed lower fungicidal concentration for isolates 1 and 2, with CFM results of 684.76 µg/mL for isolate 1 and CFM of 171.19 µg/mL for isolate 2. The three biological isolates evaluated were more sensitive to cinnamic aldehyde, isoeugenol and timol, with the following results being found for isolates 1, 2 and 3 respectively Cinnamic aldehyde - CFM 0.026µg/mL, 0.83 µg/mL and 3, 33 µg/ml; Isoeugenol CFM of 1.60 µg/ml, 1.60 µg/ml and 12.82 µg/ml; timol CFM of 2.93 µg/ml, 1.46 µg/ml and 11.74 µg/ml. The three isolates were resistant to chemical compounds α-Humulene, ßCaryophyllene, γ-Terpinene and P-Cimene. For synthetic antifungal agents, 7 the three isolates were resistant to fluconazole and voriconazole. The MIC of amphotericin B was 0.50 µg / ml for isolates 1 and 3 and 0.75 µg / ml for isolate 2; for ketoconazole, MIC was 3 µg / ml for isolates 1 and 2 and 4 µg / ml for isolate 3; the MIC of flucitocin was 2 µg / ml for isolate 1, 1 µg / ml for isolate 2 and 1.5 µg / ml for isolate 3; for itraconazole the MIC was 4 µg / ml for the three isolates. According to the conditions of this research, the essential oils of Cinnamomum cassia, Thymus vulgaris and Origanum vulgare and the chemical compounds cinnamic aldehyde, isoeugenol and thymol showed antifungal activity with the lowest concentrations of fungicides in biological isolates of Candida auris. (AU)